Survival Improved With Frontline Avelumab as Maintenance in Advanced Urothelial Carcinoma
Avelumab in combination with best supportive care as frontline maintenance in patients with advanced or metastatic urothelial carcinoma who had not progressed on first-line platinum-based chemotherapy led to improvements in both progression-free and overall survival.